vs
Ginkgo Bioworks Holdings, Inc.（DNA）与KINGSWAY FINANCIAL SERVICES INC（KFS）财务数据对比。点击上方公司名可切换其他公司
KINGSWAY FINANCIAL SERVICES INC的季度营收约是Ginkgo Bioworks Holdings, Inc.的1.2倍（$38.6M vs $33.4M），KINGSWAY FINANCIAL SERVICES INC同比增速更快（30.1% vs -23.8%），过去两年KINGSWAY FINANCIAL SERVICES INC的营收复合增速更高（21.4% vs -6.2%）
Ginkgo Bioworks Holdings, Inc.是一家2008年由五名麻省理工学院科学家创立的美国生物技术企业，由杰森·凯利掌舵。公司专注于基因工程改造，为其他生物科技企业开发具备工业应用价值的菌株，帮助合作方省去合成生物学设计初期的重复研发成本，号称「生物制造平台企业」，2019年估值就已达42亿美元。
金斯威金融服务公司是一家专业金融控股企业，主要提供财产和意外伤害保险产品，包括个人车险、商业责任险、财产险等，核心市场覆盖北美地区，服务个人消费者、小微企业主及特定商业客户群体。
DNA vs KFS — 直观对比
营收规模更大
KFS
是对方的1.2倍
$33.4M
营收增速更快
KFS
高出53.9%
-23.8%
两年增速更快
KFS
近两年复合增速
-6.2%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $33.4M | $38.6M |
| 净利润 | — | $-1.6M |
| 毛利率 | — | — |
| 营业利润率 | -211.9% | 0.8% |
| 净利率 | — | -4.1% |
| 营收同比 | -23.8% | 30.1% |
| 净利润同比 | — | -7.8% |
| 每股收益（稀释后） | $-1.41 | $-0.07 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收DNAKFS
| Q4 25 | $33.4M | $38.6M | ||
| Q3 25 | $38.8M | $37.2M | ||
| Q2 25 | $49.6M | $30.9M | ||
| Q1 25 | $48.3M | $28.3M | ||
| Q4 24 | $43.8M | $29.6M | ||
| Q3 24 | $89.0M | $27.1M | ||
| Q2 24 | $56.2M | $26.4M | ||
| Q1 24 | $37.9M | $26.2M |
净利润DNAKFS
| Q4 25 | — | $-1.6M | ||
| Q3 25 | $-80.8M | $-2.4M | ||
| Q2 25 | $-60.3M | $-3.2M | ||
| Q1 25 | $-91.0M | $-3.1M | ||
| Q4 24 | — | $-1.5M | ||
| Q3 24 | $-56.4M | $-2.3M | ||
| Q2 24 | $-217.2M | $-2.2M | ||
| Q1 24 | $-165.9M | $-2.3M |
营业利润率DNAKFS
| Q4 25 | -211.9% | 0.8% | ||
| Q3 25 | -231.8% | -2.3% | ||
| Q2 25 | -132.1% | -3.6% | ||
| Q1 25 | -184.1% | -2.5% | ||
| Q4 24 | -236.3% | 6.5% | ||
| Q3 24 | -62.0% | -2.5% | ||
| Q2 24 | -396.7% | 0.5% | ||
| Q1 24 | -469.1% | 2.9% |
净利率DNAKFS
| Q4 25 | — | -4.1% | ||
| Q3 25 | -207.9% | -6.5% | ||
| Q2 25 | -121.6% | -10.2% | ||
| Q1 25 | -188.2% | -10.9% | ||
| Q4 24 | — | -5.0% | ||
| Q3 24 | -63.3% | -8.5% | ||
| Q2 24 | -386.4% | -8.3% | ||
| Q1 24 | -437.3% | -8.9% |
每股收益（稀释后）DNAKFS
| Q4 25 | $-1.41 | $-0.07 | ||
| Q3 25 | $-1.45 | $-0.10 | ||
| Q2 25 | $-1.10 | $-0.13 | ||
| Q1 25 | $-1.68 | $-0.13 | ||
| Q4 24 | $-1.91 | $-0.08 | ||
| Q3 24 | $-1.08 | $-0.10 | ||
| Q2 24 | $-4.23 | $-0.08 | ||
| Q1 24 | $-3.32 | $-0.09 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $422.6M | $8.5M |
| 总债务越低越好 | — | $70.7M |
| 股东权益账面价值 | $508.6M | $15.2M |
| 总资产 | $1.1B | $231.5M |
| 负债/权益比越低杠杆越低 | — | 4.66× |
8季度趋势，按日历期对齐
现金及短期投资DNAKFS
| Q4 25 | $422.6M | $8.5M | ||
| Q3 25 | $495.5M | $9.5M | ||
| Q2 25 | $559.4M | $12.3M | ||
| Q1 25 | $325.3M | $6.5M | ||
| Q4 24 | $561.6M | $5.7M | ||
| Q3 24 | $616.2M | $6.7M | ||
| Q2 24 | $730.4M | $9.8M | ||
| Q1 24 | $840.4M | $12.3M |
总债务DNAKFS
| Q4 25 | — | $70.7M | ||
| Q3 25 | — | $70.7M | ||
| Q2 25 | — | $58.3M | ||
| Q1 25 | — | $59.5M | ||
| Q4 24 | — | $57.5M | ||
| Q3 24 | — | $58.5M | ||
| Q2 24 | — | $47.3M | ||
| Q1 24 | — | $47.1M |
股东权益DNAKFS
| Q4 25 | $508.6M | $15.2M | ||
| Q3 25 | $559.8M | $16.6M | ||
| Q2 25 | $613.0M | $17.4M | ||
| Q1 25 | $647.4M | $5.5M | ||
| Q4 24 | $716.1M | $8.4M | ||
| Q3 24 | $797.9M | $9.9M | ||
| Q2 24 | $833.1M | $20.7M | ||
| Q1 24 | $987.3M | $23.6M |
总资产DNAKFS
| Q4 25 | $1.1B | $231.5M | ||
| Q3 25 | $1.2B | $235.1M | ||
| Q2 25 | $1.2B | $207.7M | ||
| Q1 25 | $1.3B | $192.1M | ||
| Q4 24 | $1.4B | $186.6M | ||
| Q3 24 | $1.5B | $191.1M | ||
| Q2 24 | $1.6B | $192.3M | ||
| Q1 24 | $1.6B | $198.0M |
负债/权益比DNAKFS
| Q4 25 | — | 4.66× | ||
| Q3 25 | — | 4.25× | ||
| Q2 25 | — | 3.34× | ||
| Q1 25 | — | 10.91× | ||
| Q4 24 | — | 6.84× | ||
| Q3 24 | — | 5.88× | ||
| Q2 24 | — | 2.29× | ||
| Q1 24 | — | 2.00× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-47.7M | $-3.0K |
| 自由现金流经营现金流 - 资本支出 | $-47.7M | — |
| 自由现金流率自由现金流/营收 | -142.8% | — |
| 资本支出强度资本支出/营收 | 0.0% | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流DNAKFS
| Q4 25 | $-47.7M | $-3.0K | ||
| Q3 25 | $-31.6M | $1.5M | ||
| Q2 25 | $-40.3M | $337.0K | ||
| Q1 25 | $-51.5M | $-1.8M | ||
| Q4 24 | $-42.4M | $1.1M | ||
| Q3 24 | $-103.5M | $368.0K | ||
| Q2 24 | $-84.4M | $557.0K | ||
| Q1 24 | $-89.3M | $249.0K |
自由现金流DNAKFS
| Q4 25 | $-47.7M | — | ||
| Q3 25 | — | $1.3M | ||
| Q2 25 | $-40.3M | — | ||
| Q1 25 | $-59.1M | — | ||
| Q4 24 | $-56.1M | — | ||
| Q3 24 | $-118.6M | — | ||
| Q2 24 | $-111.4M | — | ||
| Q1 24 | $-96.0M | — |
自由现金流率DNAKFS
| Q4 25 | -142.8% | — | ||
| Q3 25 | — | 3.4% | ||
| Q2 25 | -81.2% | — | ||
| Q1 25 | -122.4% | — | ||
| Q4 24 | -128.0% | — | ||
| Q3 24 | -133.2% | — | ||
| Q2 24 | -198.2% | — | ||
| Q1 24 | -252.9% | — |
资本支出强度DNAKFS
| Q4 25 | 0.0% | — | ||
| Q3 25 | 0.0% | 0.5% | ||
| Q2 25 | 0.1% | — | ||
| Q1 25 | 15.8% | — | ||
| Q4 24 | 31.3% | — | ||
| Q3 24 | 16.9% | 0.0% | ||
| Q2 24 | 48.1% | — | ||
| Q1 24 | 17.7% | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
DNA
| Cell Engineering Segment | $26.0M | 78% |
| Other | $7.4M | 22% |
KFS
| Other | $14.8M | 38% |
| Roundhouse Electric Equipment Co Inc | $9.7M | 25% |
| MLC Plumbing LLC | $5.7M | 15% |
| Systems Products International Incspi | $3.8M | 10% |
| Advanced Plumbing And Drain | $2.9M | 8% |
| Southside Plumbing | $1.7M | 4% |
